Mark Christopher Bradley
CIK: 0002023657
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ALUMIS INC.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Aug 3, 2026ALMS
ALUMIS INC.
Sale(S)Direct2.6K shares at avg. $26.37$68K - Jan 26, 2026ALMS
ALUMIS INC.
Award(A)DirectStock Option (Right to Buy)
190.2K shares- - Jul 29, 2025ALMS
ALUMIS INC.
Award(A)Direct26.8K shares- - Feb 18, 2025ALMS
ALUMIS INC.
Award(A)DirectStock Option (Right to Buy)
140K shares-
1-4 of 4 transactions
About Bradley Mark Christopher
Bradley Mark Christopher (SEC CIK 0002023657) files insider reports with the SEC as Chief Development Officer of ALUMIS INC. (ALMS).
Signal8 holds 4 ownership filings by Bradley Mark Christopher, all Form 4s, filed between Feb 20, 2025 and Aug 5, 2026. Those filings report 4 transactions, from Feb 18, 2025 to Aug 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Bradley Mark Christopher's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Bradley Mark Christopher
Other insiders filing for ALUMIS INC. (ALMS)
- AKKARAJU SRINIVAS, Director
- Schroer John R., Chief Financial Officer
- Pangali Sanam, Chief Legal Officer
- Hardiman Roy C., Chief Business & Strategy Ofcr
- Goldstein David M, Chief Scientific Officer
- Drappa Jorn, Chief Medical Officer